MTMarie Tremblay-Franco

Marie Tremblay-Franco

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marie Tremblay-Franco has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Proton NMR Enables the Absolute Quantification of Aqueous Metabolites and Lipid Classes in Unique Mouse Liver Samples

    by Aurélien Amiel, Marie Tremblay-Franco, Roselyne Gautier, Simon Ducheix, Alexandra Montagner, Arnaud Polizzi, Laurent Debrauwer, Hervé Guillou, Justine Bertrand-Michel, Cécile Canlet

    Hepatic metabolites provide valuable information on the physiological state of an organism, and thus, they are monitored in many clinical situations. Typically, monitoring requires several analyses for each class of targeted metabolite, which is time consuming. The present study aimed to evaluate a proton nuclear magnetic resonance (1H-NMR) method for obtaining quantitative measurements of aqueous and lipidic metabolites. We optimized the extraction protocol, the standard samples, and the organic solvents for the absolute quantification of lipid species. To validate the method, we analyzed metabolic profiles in livers of mice fed three different diets. We compared our results with values obtained with conventional methods and found strong correlations. The 1H-NMR protocol enabled the absolute quantification of 29 aqueous metabolites and eight lipid classes. Results showed that mice fed a diet enriched in saturated fatty acids had higher levels of triglycerides, cholesterol ester, monounsaturated fatty acids, lactate, 3-hydroxy-butyrate, and alanine and lower levels of glucose, compared to mice fed a control diet. In conclusion, proton NMR provided a rapid overview of the main lipid classes (triglycerides, cholesterol, phospholipids, fatty acids) and the most abundant aqueous metabolites in liver.


  • Open Access

    Hepatocyte-specific deletion of Pparα promotes NASH in the context of obesity

    by Marion Régnier, Arnaud Polizzi, Sarra Smati, Céline Lukowicz, Anne Fougerat, Yannick Lippi, Edwin Fouché, Frédéric Lasserre, Claire Naylies, Colette Bétoulières, et al.

    Objectives: Peroxisome proliferator activated receptor α (PPARα) acts as a fatty acid sensor to orchestrate the transcription of genes coding for rate-limiting enzymes required for lipid oxidation in hepatocytes. Mice only lacking Pparα in hepatocytes spontaneously develop steatosis without obesity in aging. Altough steatosis is a benign condition it can develop into non alcoholic steatohepatitis (NASH), which may progress to irreversible damage, such as fibrosis and hepatocarcinoma. While NASH appears as a major public health concern worldwide, it remains an unmet medical need. Several drugs are being tested in clinical trials, including pharmacological agonists for the different PPAR isotypes. In current study, we investigated the role of hepatocyte PPARα in a preclinical model of steatosis. Methods/Results: We have investigated the role of hepatocyte PPARα in a preclinical model of steatosis using High Fat Diet (HFD) feeding as a model of obesity in C57BL/6J male Wild-Type mice ( WT ), in whole-body ( Pparα -/- ) mice and in mice lacking Pparα in hepatocyte ( Pparα hep-/- ). We provide evidence that Pparα deletion in hepatocytes promotes NASH in mice fed an HFD. This enhanced NASH susceptibility occurs without development of glucose intolerance. Moreover, our data reveal that non-hepatocytic PPARα activity predominantly contributes to the metabolic response to HFD. Conclusion: Taken together, our data support hepatocyte PPARα as being essential to the prevention of steatosis progression to NASH and that extra-hepatocyte PPARα activity contributes to whole-body lipid homeostasis. Highlights: Pparα deletion in hepatocytes promotes steatosis and inflammation in HFD-induced obesity Hepatocyte-specific deletion of Pparα dissociates NAFLD from glucose intolerance in HFD-induced obesity obesity Extrahepatic PPARα activity contributes to the metabolic response to HFD-induced obesity


  • Identification des fonctions physiologiques de PPARbeta hépatocytaire : rôle possible dans le diabète de type 2

    by Alexandra Montagner, Géraldine Michel, Edwin Fouché, Marion Régnier, Arnaud Polizzi, Céline Lukowicz, Aurélien Amiel, Frédéric Lasserre, Claire Naylies, Cécile Canlet, et al.

  • A low-dose of a complex pesticide mixture disrupts the metabolome of pregnant rats and their offspring

    by Nathalie Bonvallot, Cecile Canlet, Marie Tremblay-Franco, Florence Blas-Y-Estrada, Roselyne Gautier, Sylvaine Cordier, Jean-Pierre Cravedi


  • O-109

    by Nathalie Bonvallot, Marie Tremblay-Franco, Cecile Canlet, Cecile Chevrier, Jean-Pierre Cravedi, Sylvaine Cordier